Poliomyelitis in the United States

Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection

“…Because 90% of symptomatic UTI are uncomplicated infections, an ideal vaccine will target factors critical for establishment of bladder colonization (3). Five FDA-approved vaccines provide mucosal protection against other pathogens, including poliovirus, rotavirus, influenza virus, Salmonella enterica serovar Typhi, and Vibrio cholerae (8)(9)(10)(11). These efficacious mucosal vaccines that protect against other enteric viruses and bacteria bolster the hypothesis that a vaccine effective against uropathogens is attainable.…”

Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection

“…Because 90% of symptomatic UTI are uncomplicated infections, an ideal vaccine will target factors critical for establishment of bladder colonization (3). Five FDA-approved vaccines provide mucosal protection against other pathogens, including poliovirus, rotavirus, influenza virus, Salmonella enterica serovar Typhi, and Vibrio cholerae (8)(9)(10)(11). These efficacious mucosal vaccines that protect against other enteric viruses and bacteria bolster the hypothesis that a vaccine effective against uropathogens is attainable.…”

Plague Vaccines: Status and Future

“…There are also a number of mucosally delivered live vaccines. These include oral vaccines against poliovirus [154], cholera [155], rotavirus [156] and typhoid fever [157] and the nasally delivered vaccines against influenza [158–160]. …”

Developing live vaccines against plague

“…There are also a number of mucosally delivered live vaccines. These include oral vaccines against poliovirus [36], cholera [37], rotavirus [38] and typhoid fever [37,39] and the nasally delivered vaccines against influenza [40,41,42].…”

Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection

“…Because 90% of symptomatic UTI are uncomplicated infections, an ideal vaccine will target factors critical for establishment of bladder colonization (3). Five FDA-approved vaccines provide mucosal protection against other pathogens, including poliovirus, rotavirus, influenza virus, Salmonella enterica serovar Typhi, and Vibrio cholerae (8)(9)(10)(11). These efficacious mucosal vaccines that protect against other enteric viruses and bacteria bolster the hypothesis that a vaccine effective against uropathogens is attainable.…”

Plague Vaccines: Status and Future

“…There are also a number of mucosally delivered live vaccines. These include oral vaccines against poliovirus [154], cholera [155], rotavirus [156] and typhoid fever [157] and the nasally delivered vaccines against influenza [158–160]. …”

Developing live vaccines against plague

“…There are also a number of mucosally delivered live vaccines. These include oral vaccines against poliovirus [36], cholera [37], rotavirus [38] and typhoid fever [37,39] and the nasally delivered vaccines against influenza [40,41,42].…”

Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection

“…Because 90% of symptomatic UTI are uncomplicated infections, an ideal vaccine will target factors critical for establishment of bladder colonization (3). Five FDA-approved vaccines provide mucosal protection against other pathogens, including poliovirus, rotavirus, influenza virus, Salmonella enterica serovar Typhi, and Vibrio cholerae (8)(9)(10)(11). These efficacious mucosal vaccines that protect against other enteric viruses and bacteria bolster the hypothesis that a vaccine effective against uropathogens is attainable.…”

Plague Vaccines: Status and Future

“…There are also a number of mucosally delivered live vaccines. These include oral vaccines against poliovirus [154], cholera [155], rotavirus [156] and typhoid fever [157] and the nasally delivered vaccines against influenza [158–160]. …”

Developing live vaccines against plague

“…There are also a number of mucosally delivered live vaccines. These include oral vaccines against poliovirus [36], cholera [37], rotavirus [38] and typhoid fever [37,39] and the nasally delivered vaccines against influenza [40,41,42].…”